研究单位：[1]Sun Yat-sen University[2]The First Affiliated Hospital of Kunming Medical College Kunming,Yunnan,China[3]Peking University People's Hospital Beijing,Beijing,China,100044[4]Beijing Hospital Beijing,Beijing,China,100730[5]Chinese PLA General Hospital Beijing,Beijing,China,100853[6]Peking University First Hospital Beijing,Beijing,China[7]The Military General Hospital of Beijing PLA Beijing,Beijing,China[8]The Second Affiliated Hospital of Sun Yat-sen University Guangzhou,Guangdong,China,510000[9]The Third Affiliated Hospital of Sun Yat-sen University Guangzhou,Guangdong,China,510630[10]Qingyuan People's hospital Qingyuan,Guangdong,China,511500
研究目的：
The purpose of this study is to investigate and evaluate the effects of different interventions (1. exenatide, 2. insulin, 3. thiazolidinedione) on glycemic control and β-cell function in newly diagnosed drug-naïve type 2 diabetic patients.
